On ECHEMI
Home > Drugs > Jiangsu Morning Brand Pharmaceutical Group Co., Ltd.
Jiangsu Morning Brand Pharmaceutical Group Co., Ltd.
  • Founded in:

    1996-05-28
  • Country:

    China China
  • Address:

    No. 666, Beijing East Road, Haimen District, Nantong City, Jiangsu Province
  • Tax NO.:

    913206001388073171
  • Registered Funds:

    55 million yuan
  • Website:

  • Email:

Related Drugs
Levofloxacin Lactate Sodium Chloride Injection
Levofloxacin lactate.
Name Description Content CAS NO. Registered Holders
LEVOFLOXACIN LACTATE

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc. It also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

More

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc. It also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

294662-18-3 11
Levofloxacin Lactate Sodium Chloride Injection
Levofloxacin lactate.
Name Description Content CAS NO. Registered Holders
LEVOFLOXACIN LACTATE

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae (such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc.); it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

More

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae (such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc.); it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

294662-18-3 11
Piracetam Sodium Chloride Injection
The main ingredient of this product is piracetam. Its chemical name is: 2-oxido-1-pyrrolidinoacetamide. Excipients: sodium chloride, water for injection.
Name Description Content CAS NO. Registered Holders
Piracetam

This product is a brain metabolism improving drug, which is a cyclic derivative of г-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

More

This product is a brain metabolism improving drug, which is a cyclic derivative of г-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

7491-74-9 24
Piracetam Sodium Chloride Injection
The main ingredient of this product is piracetam. Its chemical name is: 2-oxido-1-pyrrolidinoacetamide. Excipients: sodium chloride, water for injection.
Name Description Content CAS NO. Registered Holders
Piracetam

This product is a brain metabolism improving drug, which is a cyclic derivative of г-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

More

This product is a brain metabolism improving drug, which is a cyclic derivative of г-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

7491-74-9 24
Compound Danshen Tablets
Danshen, Panax notoginseng, Borneol
Name Description Content CAS NO. Registered Holders
Salvia Root P.E Tanshinone IIA 20%

Dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids.

More

Dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids.

0
NOTOGINSENG RADIX ET RHIZOMA

Inhibit platelet aggregation, inhibit platelet release reaction, reduce blood viscosity, and lower blood lipids.

More

Inhibit platelet aggregation, inhibit platelet release reaction, reduce blood viscosity, and lower blood lipids.

0
Borneol

Compound Danshen Tablets have the effects of dilating coronary arteries, increasing coronary blood flow, slowing heart rate, and improving myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reaction, reduce blood viscosity, and lower blood lipids.

More

Compound Danshen Tablets have the effects of dilating coronary arteries, increasing coronary blood flow, slowing heart rate, and improving myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reaction, reduce blood viscosity, and lower blood lipids.

507-70-0 1
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.